Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Therapy regimens
| Characteristics, n (%) | FAS (N = 59) |
|---|---|
| Patients treated with adjuvant anti-HER2 therapy in adjuvance, n (%) | |
| Yes | 59 (100.0%) |
| Number of valid observations | 59 (100.0%) |
| Adjuvant anti-HER2 therapy, n (%) | |
| Trastuzumab-dkst only | 44 (74.6%) |
| Trastuzumab-dkst + pertuzumab | 11 (18.6%) |
| Trastuzumab-dkst + pertuzumab and trastuzumab only | 2 (3.4%) |
| Reference trastuzumab previously and trastuzumab-dkst in the study | 2 (3.4%) |
| Total participants | 59 (100.0%) |
FAS full analysis set
